PLASMA TRIGLYCERIDES DETERMINE LOW-DENSITY-LIPOPROTEIN COMPOSITION, PHYSICAL-PROPERTIES, AND CELL-SPECIFIC BINDING IN CULTURED-CELLS

被引:79
作者
MCKEONE, BJ [1 ]
PATSCH, JR [1 ]
POWNALL, HJ [1 ]
机构
[1] UNIV INNSBRUCK, DEPT MED, A-6020 INNSBRUCK, AUSTRIA
关键词
ATHEROSCLEROSIS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; APOLIPOPROTEIN-B; APO-B/E RECEPTOR;
D O I
10.1172/JCI116411
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The relationship between the plasma triglycerides and the LDL triglycerides of 30 normal and 48 hypertriglyceridemic subjects has been quantified; the data fit a simple adsorption isotherm, LDL triglyceride / (LDL triglyceride + LDL cholesterol ester) = 0.65 plasma triglyceride/(464 + plasma triglyceride). In vitro transfer of triglyceride from concentrated VLDL to VLDL-depleted plasma produced triglyceride-rich LDL that had similar properties. LDL uptake by HepG2 cells increased with LDL triglyceride content whereas the reverse was found with skin fibroblasts. At 37-degrees-C, the cores of both normal and hypertriglyceridemic LDL were isotropic liquids. Circular dichroic spectra revealed no difference in the secondary structure of normal and triglyceride-rich LDL. The affinity of monoclonal antibody MB47, which binds to the receptor ligand of apo B-100 was independent of LDL triglyceride content. MB3, which binds near residue 1022 of apo B-100, showed a triglyceride-dependent decrease in affinity for LDL from hypertriglyceridemic subjects and from in vitro incubations. LDL with an elevated triglyceride content formed in vitro had reduced proteolytic cleavage of apo B-100 by Staphylococcus aureus V8 protease. From these data, we infer that (a) LDL triglyceride is a predictable function of plasma triglyceride, (b) triglyceride induces subtle changes in apo B-100 structure at a site that is remote from the putative receptor binding ligand, and (c) the triglyceride-dependent receptor-binding determinants of apo B-100 are recognized differently by fibroblasts and HepG2 cells.
引用
收藏
页码:1926 / 1933
页数:8
相关论文
共 61 条
[21]   STIMULATION OF THE LDL RECEPTOR ACTIVITY IN THE HUMAN HEPATOMA-CELL LINE HEP G2 BY HIGH-DENSITY SERUM FRACTIONS [J].
HAVEKES, LM ;
SCHOUTEN, D ;
DEWIT, ECM ;
COHEN, LH ;
GRIFFIOEN, M ;
VANHINSBERGH, VWM ;
PRINCEN, HMG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 875 (02) :236-246
[22]   HEPATOCYTIC LIPOPROTEIN RECEPTORS AND INTRACELLULAR LIPOPROTEIN CATABOLISM [J].
HAVEL, RJ ;
HAMILTON, RL .
HEPATOLOGY, 1988, 8 (06) :1689-1704
[23]   IMMUNOBLOTTING AND LIGAND BLOTTING OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR OF HUMAN-LIVER, HEPG2 CELLS AND HELA-CELLS [J].
HAVINGA, JR ;
LOHSE, P ;
BEISIEGEL, U .
FEBS LETTERS, 1987, 216 (02) :275-280
[24]   FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 - LOW-DENSITY LIPOPROTEINS WITH ABNORMAL RECEPTOR-BINDING [J].
INNERARITY, TL ;
WEISGRABER, KH ;
ARNOLD, KS ;
MAHLEY, RW ;
KRAUSS, RM ;
VEGA, GL ;
GRUNDY, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6919-6923
[25]   PROTEIN SECONDARY STRUCTURE AND CIRCULAR-DICHROISM - A PRACTICAL GUIDE [J].
JOHNSON, WC .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1990, 7 (03) :205-214
[26]  
KESANIEMI YA, 1982, LIPOPROTEIN KINETICS, P181
[27]  
KINOSHITA M, 1990, J LIPID RES, V31, P701
[28]   ATHEROGENIC DIETS AND NEUTRAL-LIPID ORGANIZATION IN PLASMA LOW-DENSITY LIPOPROTEINS [J].
KIRCHHAUSEN, T ;
UNTRACHT, SH ;
FLESS, GM ;
SCANU, AM .
ATHEROSCLEROSIS, 1979, 33 (01) :59-70
[29]   DEFECTIVE METABOLISM OF HYPERTRIGLYCERIDEMIC LOW-DENSITY LIPOPROTEIN IN CULTURED HUMAN-SKIN FIBROBLASTS - NORMALIZATION WITH BEZAFIBRATE THERAPY [J].
KLEINMAN, Y ;
EISENBERG, S ;
OSCHRY, Y ;
GAVISH, D ;
STEIN, O ;
STEIN, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (06) :1796-1803
[30]  
KOVANEN PT, 1979, J BIOL CHEM, V254, P1367